SPARC's Q2 Financial Results Show Negative Performance and Declining Indicators
SPARC, a midcap pharmaceutical company, has reported a negative performance in the second quarter of fiscal year 2024-2025. Net sales have decreased by 24.8%, interest costs have increased significantly, and PAT and operating cash flow have declined. Key indicators such as net sales, operating profit margin, PBT, and EPS have also reached their lowest points in the last five quarters. Investors should carefully consider these factors before making any investment decisions.
Sun Pharma Advanced Research Company (SPARC), a midcap pharmaceutical company, recently declared its financial results for the quarter ending September 2024. The company's stock has been given a 'Strong Sell' call by MarketsMOJO.
According to the financial report, SPARC has seen a very negative performance in the second quarter of the fiscal year 2024-2025. The company's score has fallen from -20 to -28 in the last three months.
One of the major factors contributing to this decline is the decrease in net sales, which has fallen by 24.8% compared to the average net sales of the previous four quarters. This trend is expected to continue in the near term.
Another concerning aspect is the significant increase in interest costs, which has grown by 113,999,900.00% quarter on quarter. This indicates that the company has taken on more borrowings, which could impact its financial stability.
The company's profit after tax (PAT) has also seen a decline of 10.7% compared to the average PAT of the previous four quarters. Additionally, SPARC's operating cash flow has been consistently negative in the last three years.
In terms of sales, the company has recorded its lowest net sales in the last five quarters. Similarly, its operating profit margin has also reached its lowest point in the last five quarters, indicating a decline in efficiency.
Furthermore, the company's profit before tax (PBT) has fallen by 5.2% compared to the average PBT of the previous four quarters. This trend is reflected in the declining earnings per share (EPS), which has reached its lowest point in the last five quarters.
Overall, SPARC's financial performance for the quarter ending September 2024 has been disappointing, with several key indicators showing a negative trend. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
